Allergic Rhinitis Market Status and Trend Analysis 2017-2026 (COVID-19 Version)
- 99S4165463
- 91 Pages
- January 2021
- Diagnostic and Biotech
Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.
The global Allergic Rhinitis market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.
Based on the type of product, the global Allergic Rhinitis market segmented into
Subcutaneous Immunotherapy
Sublingual Immunotherapy
Based on the end-use, the global Allergic Rhinitis market classified into
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
Based on geography, the global Allergic Rhinitis market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]
And the major players included in the report are
Anergis
HAL Allergy Group
Merck
Allergy Therapeutics
ALK-Abello
Stallergenes Greer
Laboratorios LETI
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL ALLERGIC RHINITIS INDUSTRY
2.1 Summary about Allergic Rhinitis Industry
2.2 Allergic Rhinitis Market Trends
2.2.1 Allergic Rhinitis Production & Consumption Trends
2.2.2 Allergic Rhinitis Demand Structure Trends
2.3 Allergic Rhinitis Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Subcutaneous Immunotherapy
4.2.2 Sublingual Immunotherapy
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Hospital Pharmacies
4.3.2 Online Pharmacies
4.3.3 Retail Pharmacies
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Subcutaneous Immunotherapy
5.2.2 Sublingual Immunotherapy
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Hospital Pharmacies
5.3.2 Online Pharmacies
5.3.3 Retail Pharmacies
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Subcutaneous Immunotherapy
6.2.2 Sublingual Immunotherapy
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Hospital Pharmacies
6.3.2 Online Pharmacies
6.3.3 Retail Pharmacies
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Subcutaneous Immunotherapy
7.2.2 Sublingual Immunotherapy
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Hospital Pharmacies
7.3.2 Online Pharmacies
7.3.3 Retail Pharmacies
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Subcutaneous Immunotherapy
8.2.2 Sublingual Immunotherapy
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Hospital Pharmacies
8.3.2 Online Pharmacies
8.3.3 Retail Pharmacies
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Subcutaneous Immunotherapy
9.2.2 Sublingual Immunotherapy
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Hospital Pharmacies
9.3.2 Online Pharmacies
9.3.3 Retail Pharmacies
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Anergis
10.1.2 HAL Allergy Group
10.1.3 Merck
10.1.4 Allergy Therapeutics
10.1.5 ALK-Abello
10.1.6 Stallergenes Greer
10.1.7 Laboratorios LETI
10.2 Allergic Rhinitis Sales Date of Major Players (2017-2020e)
10.2.1 Anergis
10.2.2 HAL Allergy Group
10.2.3 Merck
10.2.4 Allergy Therapeutics
10.2.5 ALK-Abello
10.2.6 Stallergenes Greer
10.2.7 Laboratorios LETI
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
1.Table Allergic Rhinitis Product Type Overview
2.Table Allergic Rhinitis Product Type Market Share List
3.Table Allergic Rhinitis Product Type of Major Players
4.Table Brief Introduction of Anergis
5.Table Brief Introduction of HAL Allergy Group
6.Table Brief Introduction of Merck
7.Table Brief Introduction of Allergy Therapeutics
8.Table Brief Introduction of ALK-Abello
9.Table Brief Introduction of Stallergenes Greer
10.Table Brief Introduction of Laboratorios LETI
11.Table Products & Services of Anergis
12.Table Products & Services of HAL Allergy Group
13.Table Products & Services of Merck
14.Table Products & Services of Allergy Therapeutics
15.Table Products & Services of ALK-Abello
16.Table Products & Services of Stallergenes Greer
17.Table Products & Services of Laboratorios LETI
18.Table Market Distribution of Major Players
19.Table Global Major Players Sales Revenue (Million USD) 2017-2020e
20.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
21.Table Global Allergic Rhinitis Market Forecast (Million USD) by Region 2021f-2026f
22.Table Global Allergic Rhinitis Market Forecast (Million USD) Share by Region 2021f-2026f
23.Table Global Allergic Rhinitis Market Forecast (Million USD) by Demand 2021f-2026f
24.Table Global Allergic Rhinitis Market Forecast (Million USD) Share by Demand 2021f-2026f
Similar Reports
Biomaterials are materials of either synthetic or natural origin that are used for interaction with biological systems for medical purposes such as treating or repairing damage tissues. They are used in joint replacements, plastic surgeries, drug delivery devi...
- Publish Date: September 1, 2016
- $5370
The global DNA sequencing market was estimated to be $6,243 million in 2017 and is projected to reach $25,470 million in 2025 growing with a CAGR of 19% from 2018 to 2025. DNA sequencing is a type of technology in which several DNA strands can be sequenced through massive parallelization. The DNA sequencing contains both Sanger’s method of sequencing and non-Sanger’s methods of sequencing. ...
- Publish Date: May 24, 2017
- $5370
Patients with serious nervous system injuries or strokes often require lifelong assistance, which burdens patients, their families, and society. Innovative, paradigm shifting strategies are required to develop treatments for neurological injury. Early dia...
- Publish Date: May 24, 2017
- $5370
